Cytomegalovirus (CMV) is an important pathogen for both clinical and population settings. There is a growing body of research implicating CMV in multiple health outcomes across the …
Y Wang, X Yu, S Luo, H Han - Immunity & Ageing, 2015 - Springer
Background Ageing brings about the gradual deterioration of the immune system, also known as immunosenescence. The role of non-coding circular RNA in immunosenescence …
SPH van den Berg, LY Derksen, J Drylewicz… - PLoS …, 2021 - journals.plos.org
Cytomegalovirus (CMV) infection has a major impact on the T-cell pool, which is thought to be associated with ageing of the immune system. The effect on the T-cell pool has been …
L Müller, G Pawelec - Brain, behavior, and immunity, 2014 - Elsevier
Immune responses to pathogens to which they were not previously exposed are commonly less effective in elderly people than in young adults, whereas those to agents previously …
P Griffiths, S Plotkin, E Mocarski, R Pass, M Schleiss… - Vaccine, 2013 - Elsevier
Publication of a report from the Institute of Medicine in 2000 showing that a vaccine against cytomegalovirus (CMV) would likely be cost saving was very influential and encouraged the …
MI Hofstee, A Cevirgel, ML de Zeeuw-Brouwer… - Scientific Reports, 2023 - nature.com
Cytomegalovirus (CMV) is known to alter circulating effector memory or re-expressing CD45RA+ (TemRA) T-cell numbers, but whether Epstein–Barr virus (EBV) does the same or …
M Beswick, A Pachnio, SN Lauder, C Sweet… - Journal of …, 2013 - Am Soc Microbiol
Cytomegalovirus (CMV) infection leads to the development of adaptive and humoral immune responses that are among the largest for any pathogen, and intriguingly, the …
Increased life expectancy due to improved efficacy of cART has uncovered an increased risk of age-related morbidities in HIV+ individuals and catalyzed significant research into …